Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sabina Kaczanowska"'
Autor:
Shil Patel, Justin Drake, Rosandra N. Kaplan, Katherine A. Alexander, Miranda E. Clements, Michael C. Kelly, Kristin M. Wessel, Haiying Qin, Sabina Kaczanowska, Vishaka Gopalan, Wei Ju, Meera Murgai, Chiadika Nwanze, Daniel W Beury, Sridhar Hannenhalli, Jessica Kline, Arielle K. Tycko, Cristina F. Contreras, Zachary Rae
Publikováno v:
Cell
Summary Metastasis is the leading cause of cancer-related deaths, and greater knowledge of the metastatic microenvironment is necessary to effectively target this process. Microenvironmental changes occur at distant sites prior to clinically detectab
Autor:
Jiajia Zhang, Dipti Thakkar, Vaia Florou, Rachel Howard, Rania H. Younis, Esha Sachdev, Aideen E. Ryan, Christopher A. Fuhrman, Rosa Nguyen, Abigail E. Overacre-Delgoffe, Sabina Kaczanowska, Maria E. Rodriguez-Ruiz, Thomas U. Marron, Daniel J Olson, Jennifer L. Guerriero, Todd Bartkowiak, Jessica E. Thaxton, Sarah E. Church, David H. Aggen, Michal Sheffer, Ravi Patel, Sangeetha M. Reddy, Kristin G. Anderson, Abdul Rafeh Naqash
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients, however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to treat patients with metastatic melanoma, a condition that at the tim
Autor:
Engin Kaptan, Stuart S. Martin, Hafiz Ahmed, Sabina Kaczanowska, Gerardo R. Vasta, Keyata Thompson, Prasun Guha, Dhananjaya V. Kalvakolanu, Eduardo Davila, Gargi Bandyopadhyaya
Publikováno v:
Proceedings of the National Academy of Sciences. 110:5052-5057
Cancer metastasis and immune suppression are critical issues in cancer therapy. Here, we show that a β-galactoside–binding lectin [galectin-3 (gal3)] that recognizes the Thomsen-Friedenreich disaccharide (TFD, Galβ1,3GalNAc) present on the surfac
Publikováno v:
Journal of leukocyte biology. 93(6)
Review on the ability of different TLR agonists to orchestrate antitumor immune responses, or promote tumor growth, underscoring the impact of choosing among TLR agonists when applying these therapies in the clinic. Various TLR agonists are currently